Huang Biying, Kechagias Aristotelis, Tsekrekos Andrianos, Lovece Andrea, Hayami Masaru, Rouvelas Ioannis
Department of Upper Abdominal Surgery, Karolinska University Hospital, Stockholm, Sweden.
Department of Digestive Surgery, Kanta-Häme Central Hospital, Hämeenlinna 13530, Finland.
Int J Surg Case Rep. 2021 Jul;84:106164. doi: 10.1016/j.ijscr.2021.106164. Epub 2021 Jun 30.
Introduction of multimodality treatment as the standard of care for management of esophageal and gastroesophageal junction (GEJ) cancer over the last years has led to significant improvement in survival for patients with localized disease. Nevertheless, treatment with curative intent is not considered in the case of metastatic disease. We report a case of a locally advanced GEJ adenocarcinoma with solitary resectable synchronous metastases at the jejunum and a good response to neoadjuvant therapy followed by esophagectomy with curative intention.
This is the case of a patient with poorly differentiated adenocarcinoma of the GEJ with synchronous metastases at the jejunum. The patient underwent extensive work-up including PET-CT. The metastases at the jejunum were completely resected during an initial staging laparoscopy and there was no evidence of further metastatic disease. The patient received chemotherapy and re-staging showed remarkable tumor response. Esophagectomy with curative intent was performed. Histopathology showed complete pathologic response after chemotherapy. Although our patient had a stage IV disease at presentation, he remained metastasis-free for a significant period of time, with no evidence of any distant recurrence during a follow-up of 16 months after esophagectomy.
Synchronous metastasis to the small bowel from an esophageal carcinoma is a rare entity. Routine PET-CT in addition to conventional CT may assist in more precise staging of a patient with resectable disease. Stage IV esophageal cancer with limited and resectable metastatic disease and good tumor response to oncological therapy may be considered for treatment with potentially curative intent.
在过去几年中,多模式治疗已成为食管和胃食管交界(GEJ)癌治疗的标准护理方式,这使得局限性疾病患者的生存率有了显著提高。然而,对于转移性疾病患者,不考虑进行根治性治疗。我们报告了一例局部晚期GEJ腺癌患者,其空肠有孤立性可切除的同步转移灶,新辅助治疗后反应良好,随后进行了根治性食管切除术。
该患者为GEJ低分化腺癌,伴有空肠同步转移。患者接受了包括PET-CT在内的全面检查。在初次分期腹腔镜检查时,空肠转移灶被完全切除,且没有进一步转移疾病的证据。患者接受了化疗,重新分期显示肿瘤反应显著。进行了根治性食管切除术。组织病理学显示化疗后有完全病理反应。尽管我们的患者初诊时为IV期疾病,但在食管切除术后16个月的随访中,他在相当长一段时间内无转移,没有任何远处复发的迹象。
食管癌同步转移至小肠是一种罕见情况。除传统CT外,常规PET-CT可能有助于更精确地对可切除疾病患者进行分期。对于IV期食管癌,若有局限性且可切除的转移疾病,且肿瘤对肿瘤治疗反应良好,可考虑进行潜在根治性治疗。